The study of longevity captivates many researchers, focusing on how to extend human lifespans while simultaneously preventing diseases and age-related decline.
There are various ways to examine this topic, from our genetic makeup to dietary habits throughout life.
Currently, a global research team suggests that efforts to enhance longevity should begin as early as possible, even before birth.
In a Correspondence paper in Nature Health, the researchers advocate for a “life-course consortium for healthy longevity medicine” named PROSPER, which stands for Pregestational and Pediatric Research for Optimal Healthspan and Early-life Resilience.
frameborder=”0″ allow=”accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share” referrerpolicy=”strict-origin-when-cross-origin” allowfullscreen>
The researchers argue that too much focus on longevity research happens in the later stages of life, when much of the body’s wear and damage may already have occurred.
“Healthy longevity medicine – which seeks to translate insights from biogerontology into clinical practice – has primarily focused on adult populations, and interventions are applied only after decades of accumulated molecular and cellular changes associated with aging,” write the researchers.
“This approach overlooks a critical window of opportunity.”
The paper notes that while ample previous research has examined childhood factors affecting lifespan, there is still a lack of unified thinking in assessing aging throughout an entire lifetime.
The researchers highlight that aging markers used in adults cannot be directly applied to children, as they may signify different things at younger ages. This inconsistency is one area a consortium like PROSPER could address.
“Central to this effort is the recognition that biological age in early life reflects developmental synchrony and resilience rather than cumulative damage, which necessitates age-specific models, biomarkers and interpretative frameworks,” write the researchers.
They also discuss the concept of ‘peakspan,’ which refers to the period when individuals are at their peak performance. Everyone experiences it, though it may pass unnoticed.
This perspective on aging considers not just the length of life or the disease-free years, but also the portion of life spent in one’s prime.
“This involves the systematic integration of multiomics data, clinical phenotypes and functional measures across developmental stages, which will enable the construction of longitudinal biological trajectories that can inform risk prediction and intervention,” write the researchers.
“In parallel, the consortium seeks to develop age-specific diagnostic and therapeutic frameworks that can be embedded within routine obstetric and pediatric care, and thereby shift the focus from reactive disease management to proactive trajectory optimization.”
Currently, this proposal is in its infancy and lacks detailed plans. The PROSPER initiative aims to cover everything from clinical guidelines to medical trials, consolidating data in a novel way.
If this initiative progresses, it humorously suggests Dick van Dyke might have a consultancy role.
The experts behind this concept are specialists in the field of longevity, and if the broader scientific community endorses their proposal, it could lead to significant discoveries in longevity research, benefiting individuals at all ages.
“The establishment of a life-course consortium for healthy longevity medicine should improve research and clinical practice,” write the researchers.
Related: People Who Live to 100 Have One Thing in Common – And It’s Not Just Diet
“By aligning disciplines that have traditionally operated in isolation, it becomes possible to address the full continuum of biological aging from its earliest determinants to its clinical manifestations.”
The research has been published in Nature Health.
This article was fact-checked by Rachel Garner and edited by Michael Irving. While we pride ourselves on our process, we are only human. If you spot a mistake, please let us know.
